MetaVia SG&A Expense (Semi Annual) Analysis

MetaVia, Inc. (MTVA)

1.23 -0.03 (-2.38%) USD | NASDAQ | Apr 06, 16:00

1.26 +0.03 (+2.44%) After-Hours: 20:00

View SG&A Expense (Semi Annual) for MTVA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (Semi Annual) Chart

Start Trial

View Historical Data

Start Trial

View SG&A Expense (Semi Annual) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View SG&A Expense (Semi Annual) Benchmarks

Start Trial

Aethlon Medical, Inc.	--
Tonix Pharmaceuticals Holding Corp.	--
Phio Pharmaceuticals Corp.	--
Jaguar Health, Inc.	--
Seastar Medical Holding Corp.	--